Two-stage treatment for diabetic foot: Surgical peripheral revascularization and minor amputation in day-surgery admission  by Rivolta, Nicola et al.
lable at ScienceDirect
International Journal of Surgery 6 (2008) S75–S77Contents lists avaiInternational Journal of Surgery
journal homepage: www.thei js .comTwo-stage treatment for diabetic foot: Surgical peripheral revascularization
and minor amputation in day-surgery admission
Nicola Rivolta*, Gabriele Piffaretti, Matteo Tozzi, Chiara Lomazzi, Simona Maida, Francesca Riva,
Elena Buscarini, Patrizio Castelli
Vascular Surgery, Department of Surgical Sciences, University of Insubria, Varese, Italya r t i c l e i n f o
Article history:
Available online 13 December 2008
Keywords:
Diabetic foot
VAC-therapy
Day surgery* Corresponding author. Tel.: þ39 0332278224; fax
E-mail address: nicolarivolta@yahoo.it (N. Rivolta)
1743-9191/$ – see front matter  2008 Surgical Asso
doi:10.1016/j.ijsu.2008.12.015a b s t r a c t
Diabetic foot is complex and difﬁcult to treat. More aggressive treatment using peripheral distal by-pass
frequently combined to minor amputations has greatly improved limb salvage in most patients.
However, diabetes-related amputations are at high risk of non-healing or superinfection, thus requiring
a second-step surgical revision treatment more frequently than in non-diabetic patients. Several
advanced technologies have been developed to improve the treatment of diabetic foot wounds including
Vacuum Assisted Therapy: we present 3 cases of diabetic patients treated with preliminary surgical
peripheral revascularization, subsequent minor amputation in combination with Vacuum Assisted
Therapy performed in a day-surgery regime.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Diabetic foot still remains a clinical and technical challenge for
the vascular surgeon; local or extensive infection still threaten
those presenting with critical limb ischemia (CLI). The results of
successful peripheral revascularisation potentially improve limb
salvage allowing to be more conservative in terms of amputation.1,2
Peripheral by-pass graft surgery or endovascular treatment such
as percutaneous transluminal angioplasty (PTA) achieved
progressively improved results but revascularization alone often
still might not avoid minor amputations.1,2 Amputation wounds in
diabetic patients are one of the most challenging to heal, especially
in the foot: they are wide with exposed bone and tendons, and
occurred in people with compromised healing capacity.3,4 In the
last years new advanced technologies have been developed to
improve the treatment of diabetic foot wounds: negative-pressure
wound therapy (NPWT) has recently emerged as an adjunct for the
treatment of complex wounds with reported excellent results but
in limited series or anecdotal reports.5–7
We present 3 cases of diabetic patient with foot gangrene
treated with a multimodal approach consisting of conventional
preliminary peripheral revascularization, and subsequent minor
amputation with NPWT adjunct to support wound healing
performed in a day-surgery regimen.: þ39 0332278581.
.
ciates Ltd. Published by Elsevier Lt1.1. Case report #1
She is an 80-year-old female affected by type-II diabetes and
arterial hypertension; on initial admission, she complained right
foot rest pain and localized wet gangrene of the ﬁrst toe (grade III,
category 5 according to the Rutherford classiﬁcation reported in the
TASC II document8). Preoperative ankle-brachial index was 0.40;
computed-tomography angiography (CT-A) revealed a totally
occluded superﬁcial femoral artery with absence of run off (class D
according to the TASC II9 classiﬁcation). We performed a throm-
boendarterectomy of the common femoral artery and tibio-peroneal
trunk, and a subsequent conventional surgical femoro-popliteal by-
pass with in situ vein graft. Bacterial culture of the wet gangrene
resulted positive for Escherichia coli: hence, she started intravenous
speciﬁc antibiotic therapy with cefotaxime (Zariviz-Sanophi-
Aventis, Milano-IT) for two weeks. She was discharged on day seven
postoperatively on oral anticoagulation with symptoms relief, and
admitted to the rehabilitation ward for two weeks. Clinical visit two
weeks after the intervention revealed an improved right ankle-
brachial index of 0.68. When the ﬁrst toe lesion was delineated, on
a day-surgery regime we performed a minor amputation, and
applied the NPWT assisted therapy (VAC-KCI Medical, Assago-MI,
IT) in the same session. The patientwent home the day after. A steady
increase in the percentage of granulation tissue coverage was
noticeable; NPWT was continued for a total period of six weeks, the
overall wound dimensions decreased to lie ﬂush with surrounding
tissue. At 3-months follow-up visit, color-Doppler scan revealed the
patency of the by-pass graft and continue integrity of the wound.d. All rights reserved.
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He is a 71-year-old male affected by type-II diabetes and history
of smoking; his medical history included a prior coronary artery
endovascular revascularization PTCA-stent. He presented at our
Department with right digital gangrene and rest pain (grade III,
category 5 according to the Rutherford classiﬁcation). Resting
ankle-brachial index was 0.38; CT-A revealed a totally occluded
superﬁcial femoral artery, and one-vessel run-off on the posterior
tibial artery (class D according to the TASC II classiﬁcation). Surgical
femoro-posterior tibial by-pass was performed with in situ vein
graft. The bacterial culture of the woundmaterial was positive for E.
coli, meticyllin-sensitive Staphylococcus aureus and Proteus mir-
abilis; hence, he started an intravenous antibiotic therapy with
association of glycopeptide (Vancocina-HIKMA, Pavia-IT) and
carbapenem (Merrem-AstraZeneca, Basiglio-IT) for the following
two weeks. He was discharged on day ten postoperatively, on
a regimen of oral anticoagulation with resolution of rest pain, and
admitted to rehabilitation ward for two weeks. Two weeks follow-
up visit revealed a right ankle-brachial index of 0.70. Two weeks
later, a trans-metatarsal amputation was performed in a day-
surgery regime; during the same session a NPWT was assessed.
Complete remission of the wounded area had been reached within
two months.
1.3. Case report #3
He is a 60-year-old male affected by type-I diabetes, ischemic
heart disease, dislypidemia and arterial hypertension; medical
history included previous right iliac endovascular revascularization
with stent supported angioplasty. He was admitted to our
Department complaining right lower limb rest pain and a wet
gangrene of the ﬁrst and second toes (grade III, category 6
according to the Rutherford classiﬁcation); resting ankle-brachial
index was 0.32. Preliminary CT-A showed the stenosis of the
superﬁcial femoral artery, an occluded popliteal artery, and a two-
vessels run-off of the anterior and posterior tibial arteries. The
patient underwent surgical peripheral revascularization with
below-knee femoro-popliteal with a composite graft of short
segment autologous reversed great saphenous vein and armed
heparin-bonded ePTFE graft (Propaten-W.L.Gore & ass.). Bacterial
culture of the wound material was positive for methicillin resistant
Staphylococcus epidermidis, Corynebacterium sporidium and P. mir-
abilis; a speciﬁc antibiotic therapy with piperacillin/tazobactam
(Tazocin-WJETH-Lederle, Aprilia-IT) plus glycopeptide was
commenced for four weeks. He was discharged to rehab ward two
weeks after the intervention. One-month follow-up visit showed
the presence of tissue loss involving all digits extending to the
dorsum of the foot; the plantar aspect was spared. Color-Doppler
scan conﬁrmed the patency of the by-pass graft and the presence of
the two-vessels run-off; on a day-surgery regime, we performed
a trans-metatarsal amputation with partial closure of the wound
supported by NPWT. At 3-months follow-up, the wound was
healed.
2. Discussion
Patients with diabetic foot remains a clinical and surgical chal-
lenge for the vascular surgeon; most of the authors would agree
that extensive heel or forefoot necrosis are the most important
predictors for poor outcome in terms of limb salvage.10 Primarily,
the aim of peripheral revascularisation is to provide sufﬁcient blood
ﬂow to relieve rest pain and facilitate skin wounds healing; during
the last decade, the results of peripheral revascularization (e.g.
femoro-distal by-pass or PTA) in diabetic patients presenting withCLI have improved, with acceptable limb salvage rate and a peri-
operative mortality of <5%.10–12
However, even after successful revascularization local wound
treatment must be continued and minor amputation might be
performed if appropriate in order to defend limb salvage. It is well
known that diabetics have altered wound healing, and a number of
factors including impaired neutrophil chemotaxis and phagocy-
tosis, decreased microperfusion, and increased degradation of
important structural proteins, are involved to delay or worsen the
healing process.5,10,12 Although several advanced technologies have
been developed to improve the treatment of diabetic foot wounds,
outcomes are still not completely acceptable and many technolo-
gies have been no more beneﬁcial than simple care consisting of
appropriate debridement.12,13 One of themost recently wound-care
treatment involves the application of negative pressure to the
wound.14,15 The sub-atmospheric (e.g. negative) pressure system
uses latex-free and sterile polyurethane or polyvinyl alcohol foam
dressing that is ﬁxed at the bedside to the appropriate size for every
wound, and then covered with an adhesive drape to create an
hermetic seal. A therapeutic regulated accurate care pad (TRAC-
KCI Medical, Assago-MI, IT) lies on top of the foamwithin the drape,
and accurately senses, monitors, and maintains the target pressure
at the wound site to provide controlled negative pressure. Tubing
attached to the TRAC pad was connected to a ﬂuid collection
canister contained in a programmable, portable, computer-
controlled vacuum pump creating negative pressure at the wound
surface interface. A negative-pressure wound environment has
been suggested to transiently increase blood ﬂow with a peak
increase at 125 mmHg; as a consequence, granulation tissue has
been noted more vigorous in wounds treated with VAC therapy
than in those receiving moist dressings or other available medica-
tion.14,15 In addition, VAC therapy enhances bacterial clearance
from chronic wounds as measured by quantitative culture. These
effects address many of the wound-healing deﬁcits noted above in
diabetic patients, and these wide foot wounds should beneﬁt from
the improved microcirculation, bacterial clearance, and promotion
of granulation tissue.
Up to date, few anecdotal reports have been reported in literature
dealing with VAC treatment of diabetic foot ulcers. Armstrong and
Lavery.5 studied trans-metatarsal amputationwounds in 162 patients
by comparing NPWT with modern moist wound treatment and
concluded that the VAC system seems to be a safe and effective
treatment for complex diabetic foot wounds. In a study by Eto¨z et al.6
on diabetic foot ulcers, the formation of granulation tissue in their VAC
group of patients was faster and that the surface area of the ulcer
improvedmore consistently if compared to thosepatients treatedwith
saline bandages. In the report of Eginton et al.7 the authors compared
the VAC systemwith moist wound treatment and concluded that the
volume of the ulcer diminished more in the VAC system, but no
signiﬁcant difference of the surface area width was noted.
Although no guidelines are not still available on this topic, it has
been suggested to use the VAC systemwhereno signiﬁcant infection
organgrene in thewoundarepresent5,15: thepresent series reported
similar encouraging results in a particular subgroup of diabetic
patients, those with delineated wounds after successful revascu-
larization andminoramputation.Ourexperience supports theuseof
VAC system for those patients with complex wounds requiring
prolonged and extensive complexmedication in an anatomic setting
at higher risk of infection or threatened healing; the selective use of
VAC system in the here reported cases allowed to achieve the
complete healing of thewounds in an average period of 2.5-months,
quite better than the reported 4-months with the use of standard
availablemedication.5–7 Of note, similarly to the previous reportswe
did not observe disturbing or adverse events such as superinfection,
irritation of the skin and pain at the dressing change.11
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conﬁrm that preliminary revascularization is mandated; VAC
therapy seems to be effective andwell tolerated to support complex
medication after minor foot amputation, leading to a rapid ambu-
latory discharge of the operated patient. Nevertheless, it should be
remembered that this complex medication does not replace
surgical debridement, a manoeuvre to stimulate blood microcir-
culation and a relevant treatment to control local infection. Actu-
ally, major drawbacks of this new wound treatment could be
related to the currently not user-friendly devices, that are also not
widely available in most of the hospitals, and the costs of the
prolonged period of pad rent and speciﬁc medication.Conﬂict of interest
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